NCT05461144

Brief Summary

This observational study aims to recruit up to thirty T1DM patients from a diabetic outpatient clinic at the University Hospital Coventry and Warwickshire for a two-phase study. The first phase involves attending an inpatient protocol for up to thirty-six hours in a calorimetry room at the Human Metabolism Research Unit under controlled conditions, followed by a phase of free-living, for up to three days, in which participants will go about their normal daily activities without restriction. Throughout the study, the participants will wear commercially available wearable sensors to measure and record physiological signals (e.g., electrocardiogram and continuous glucose monitor). Data collected will be used to develop and validate an AI model using state-of-the-art deep-learning methods for the purpose of non-invasive glycaemic event detection.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
11mo left

Started Sep 2022

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Sep 2022May 2027

First Submitted

Initial submission to the registry

June 24, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

July 15, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

September 30, 2022

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Expected
Last Updated

July 15, 2022

Status Verified

July 1, 2022

Enrollment Period

3.6 years

First QC Date

June 24, 2022

Last Update Submit

July 12, 2022

Conditions

Keywords

Endochrine

Outcome Measures

Primary Outcomes (1)

  • Interstitial Glucose

    As measured by a continuous glucose monitor \[NOTE\] Observational study thus a key measurement not a true outcome measure.

    For the duration of the study, up to 5 days

Secondary Outcomes (4)

  • ECG -Interval across different fiducial points

    For the duration of the study, up to 5 days

  • ECG - Slope across different fiducial points

    For the duration of the study, up to 5 days

  • ECG - Indices of Heart Rate Variability

    For the duration of the study, up to 5 days

  • Blood Pressure (Systolic and Diastolic)

    For the duration of the study, up to 5 days

Study Arms (1)

Type1diabetes patients

Males and females diagnosed with T1D, aged over 18 years old who are currently under the care of the Warwickshire Institute for the Study of Diabetes, Endocrinolgy and Metabolism (WISDEM) at the University Hospitals Coventry and Warwickshire.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The population will be recruited from the Warwickshire Institute for the study of diabetes, Endocrinology and Metabolism, at the University Hospitals Coventry and Warwickshire. WISDEM is a flagship partnership between the hospitals and the University of Warwick Medical School created to tackle diabetes and related metabolic conditions.

You may qualify if:

  • The study will be open to all individuals living independently, over 18 years without acute illness or ongoing clinical investigation, or volunteers with a stable medical condition may be included. Volunteers with an ongoing medical condition will only be included after detailed consultation with our clinical and dietetics members of the team; however, it is imperative that volunteers are able to provide written informed consent.

You may not qualify if:

  • Children (under 18 yrs)
  • Any adult who lacks decisional capacity
  • Claustrophobia, isolophobia, recent abnormal exercise, radiation exposure within the preceding 24 hours of entering the whole-body calorimeter and feeling unwell in any way.
  • Needle phobia
  • Any medical/endocrine problem that could affect energy expenditure (e.g. thyroid problems, Cushing's syndrome)
  • Chronic inflammatory disorders like rheumatoid arthritis, or long term use of steroids or other immunomodulators like cyclosporine, azathioprine.
  • Beta blockers
  • Currently actively losing weight
  • Depression or any psychiatric illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Porumb M, Stranges S, Pescape A, Pecchia L. Precision Medicine and Artificial Intelligence: A Pilot Study on Deep Learning for Hypoglycemic Events Detection based on ECG. Sci Rep. 2020 Jan 13;10(1):170. doi: 10.1038/s41598-019-56927-5.

    PMID: 31932608BACKGROUND
  • Porumb M, Griffen C, Hattersley J, Pecchia L. Nocturnal low glucose detection in healthy elderly from one-lead ECG using convolutional denoising autoencoders. Biomedical Signal Processing and Control. 2020;62:102054.

    BACKGROUND
  • Cisuelo O, Stokes K, Oronti IB, Haleem MS, Barber TM, Weickert MO, Pecchia L, Hattersley J. Development of an artificial intelligence system to identify hypoglycaemia via ECG in adults with type 1 diabetes: protocol for data collection under controlled and free-living conditions. BMJ Open. 2023 Apr 18;13(4):e067899. doi: 10.1136/bmjopen-2022-067899.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Saliva samples for circadian biomarkers (cortisol, melatonin) Plasma for endocrine markers (insulin and glucose)

MeSH Terms

Conditions

Metabolic Diseases

Condition Hierarchy (Ancestors)

Nutritional and Metabolic Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2022

First Posted

July 15, 2022

Study Start

September 30, 2022

Primary Completion

May 1, 2026

Study Completion (Estimated)

May 1, 2027

Last Updated

July 15, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share